Structural determinants of specificity in the cysteine protease cruzain

The structure of cruzain, an essential protease from the parasite Trypanosoma cruzi, was determined by X‐ray crystallography bound to two different covalent inhibitors. The cruzain S2 specificity pocket is able to productively bind both arginine and phenylalanine residues. The structures of cruzain bound to benzoyl‐Tyr‐Ala‐fluoromethyl ketone and benzoyl‐Tyr‐Ala‐fluoromethyl ketone at 2.2 and 2.1 Å, respectively, show a pH‐dependent specificity switch. Glu 205 adjusts to restructure the S2 specificity pocket, conferring tight binding to both hydrophobic and basic residues. Kinetic analysis of activated peptide substrates shows that substrates placing hydrophobic residues in the specificity pocket are cleaved at a broader pH range than hydrophilic substrates. These results demonstrate how cruzain binds both basic and hydrophobic residues and could be important for in vivo regulation of cruzain activity.

[1]  R J Fletterick,et al.  Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix. , 1997, Biochemistry.

[2]  R. Huber,et al.  The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities. , 1996, The EMBO journal.

[3]  R. Coulombe,et al.  Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. , 1996, Structure.

[4]  J. Scharfstein,et al.  Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. , 1996, The Biochemical journal.

[5]  W. Souza,et al.  High resolution localization of cruzipain and Ssp4 in Trypanosoma cruzi by replica staining label fracture , 1996 .

[6]  C. P. Huber,et al.  Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. , 1995, The Journal of Biological Chemistry.

[7]  R. Huber,et al.  Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. , 1995, Biochemistry.

[8]  R J Fletterick,et al.  The crystal structure of cruzain: a therapeutic target for Chagas' disease. , 1995, Journal of molecular biology.

[9]  C. P. Huber,et al.  Crystal Structures of Recombinant Rat Cathepsin B and a Cathepsin B-Inhibitor Complex , 1995, The Journal of Biological Chemistry.

[10]  C. Craik,et al.  Structural basis of substrate specificity in the serine proteases , 1995, Protein science : a publication of the Protein Society.

[11]  P. Berti,et al.  Alignment/phylogeny of the papain superfamily of cysteine proteases. , 1995, Journal of molecular biology.

[12]  P. Bonneau,et al.  Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity. , 1994, The Journal of biological chemistry.

[13]  C. Turck,et al.  The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites. , 1994, The Journal of biological chemistry.

[14]  R. Fletterick,et al.  Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi. , 1993, The Journal of biological chemistry.

[15]  A. Mills,et al.  Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. , 1993, Molecular and biochemical parasitology.

[16]  Axel T. Brunger,et al.  Assessment of Phase Accuracy by Cross Validation: the Free R Value. Methods and Applications , 1993 .

[17]  A. Brünger Assessment of phase accuracy by cross validation: the free R value. Methods and applications. , 1993, Acta crystallographica. Section D, Biological crystallography.

[18]  C. Craik,et al.  The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. , 1992, The Journal of biological chemistry.

[19]  W. Rutter,et al.  Converting trypsin to chymotrypsin: the role of surface loops. , 1992, Science.

[20]  D A Agard,et al.  Structural basis for broad specificity in alpha-lytic protease mutants. , 1993, Biochemistry.

[21]  Robert Huber,et al.  The refined 2.15 A X‐ray crystal structure of human liver cathepsin B: the structural basis for its specificity. , 1991, The EMBO journal.

[22]  R. Ménard,et al.  A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses. , 1991, The Biochemical journal.

[23]  G. Gescheidt,et al.  MoMo: a Molecular-Modelling Program , 1991, CHIMIA.

[24]  J. Sack,et al.  CHAIN — A crystallographic modeling program , 1988 .

[25]  P. Rosenthal,et al.  A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. , 1988, The Journal of clinical investigation.

[26]  R. Bott,et al.  Designing substrate specificity by protein engineering of electrostatic interactions. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Ponder,et al.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. , 1987, Journal of molecular biology.

[28]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[29]  T. Creighton Proteins: Structures and Molecular Properties , 1986 .

[30]  W. Rutter,et al.  Redesigning trypsin: alteration of substrate specificity. , 1985, Science.

[31]  Alan J. Barrett,et al.  [41] Cathepsin B, cathepsin H, and cathepsin L , 1981 .

[32]  A. Barrett,et al.  Cathepsin B, Cathepsin H, and cathepsin L. , 1981, Methods in enzymology.

[33]  W. Wooster,et al.  Crystal structure of , 2005 .

[34]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.